ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ARTH Arch Therapeutics Inc (QB)

1.96
0.145 (7.99%)
Last Updated: 11:24:31
Delayed by 15 minutes

Arch Therapeutics (QB) Financial Summary

The current ARTH market cap is 9.3M. The company's latest EPS is USD -1.4725 and P/E is -1.33.

Year End September 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0012k16k76k
Operating Income -6.37M-5.37M-6.39M-5.71M-5.04M
Net Income -4.55M-4.69M-6.25M-5.28M-6.98M
Year End September 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 2.9M2.15M3.68M2.6M1.96M
Total Liabilities 3.71M3.65M4.7M6.8M9.47M
Total Equity -807k-1.5M-1.03M-4.19M-7.51M

Cash Flow

Year End September 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -5.27M-5.05M-5.96M-4.46M-3.37M
Investing N/A -2k-3k N/A -5k
Financing 2.78M3.83M7.27M2.94M2.86M
Market Cap 9.3M
Price to Earnings Ratio -1.33
Price to Sales Ratio 122.5
Price to Cash Ratio 41.7
Price to Book Ratio -1.24
Dividend Yield -

Share Statistics

Shares Outstanding 4.74M
Average Volume (1 week) 1.5k
Average Volume (1 Month) 2.33k
52 Week Change -37.78%
52 Week High 18.00
52 Week Low 0.39
Spread (Intraday) 0.11 (5.61%)

Company Info

Company Name Arch Therapeutics Inc (QB)
Address 769 basque way
carson city, nevada 89706
Website https://www.archtherapeutics.com
Industry surgical,med instr,apparatus (3841)

Your Recent History

Delayed Upgrade Clock